ASP Isotopes (ASPI) Set to Announce Quarterly Earnings on Thursday

ASP Isotopes (NASDAQ:ASPI) is anticipated to announce its Q3 2026 resultson Thursday, November 12th. Analysts expect the company to announce earnings of ($0.15) per share and revenue of $5.68 million for the quarter. Investors are encouraged to explore the company’s upcoming Q3 2026 earnings overview page for the latest details on the call scheduled for Friday, November 20, 2026 at 8:30 AM ET.

ASP Isotopes (NASDAQ:ASPI) last released its quarterly earnings data on Friday, August 14th. The company reported ($0.28) EPS for the quarter, missing the consensus estimate of ($0.17) by ($0.11). The business had revenue of $5.12 million for the quarter, compared to analysts’ expectations of $4.47 million. ASP Isotopes had a negative net margin of 427.98% and a negative return on equity of 64.99%.

ASP Isotopes Trading Up 5.5%

Shares of NASDAQ:ASPI opened at $1.91 on Thursday. The company has a current ratio of 3.87, a quick ratio of 3.85 and a debt-to-equity ratio of 0.76. The company has a 50-day moving average price of $2.85 and a two-hundred day moving average price of $4.79. ASP Isotopes has a twelve month low of $1.78 and a twelve month high of $9.38.

Insider Transactions at ASP Isotopes

In other news, Director John Ryan acquired 15,000 shares of the firm’s stock in a transaction on Wednesday, September 30th. The shares were purchased at an average price of $2.68 per share, for a total transaction of $40,200.00. Following the completion of the transaction, the director owned 675,222 shares of the company’s stock, valued at $1,809,594.96. The trade was a 2.27% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Paul Mann sold 83,759 shares of the company’s stock in a transaction dated Friday, September 4th. The shares were sold at an average price of $4.10, for a total transaction of $343,411.90. Following the transaction, the chief executive officer directly owned 9,328,570 shares of the company’s stock, valued at approximately $38,247,137. This trade represents a 0.89% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold 245,285 shares of company stock worth $899,887 in the last three months. Corporate insiders own 14.40% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have issued reports on ASPI shares. Weiss Ratings reissued a “sell (d-)” rating on shares of ASP Isotopes in a report on Monday, September 21st. Wall Street Zen upgraded ASP Isotopes from a “strong sell” rating to a “sell” rating in a research note on Saturday, August 22nd. Two investment analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $12.00.

ASP Isotopes Company Profile

ASP Isotopes Inc is a materials and technology company developing isotope-enrichment processes for use in the medical, semiconductor and nuclear-energy industries. Its primary technology is the Aerodynamic Separation Process, a proprietary method designed to separate isotopes based on differences in molecular mass and aerodynamic behavior.

The company is pursuing the production of enriched isotopes, including materials intended for applications such as semiconductor manufacturing, medical diagnostics and treatment, advanced nuclear fuels, and other industrial and scientific uses.